An Open-label, Single-arm, Phase 1b/ 2 Study of Carfilzomib in Combination With Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Latest Information Update: 26 Nov 2017
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 16 Nov 2014 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record.
- 04 Nov 2013 New trial record